The high cost of care and limited evidence on cost-effective strategies for Lewy body dementia: systematic review of evidence
Erin Boland(RTI International), Irina Kinchin(Trinity College Dublin), Iracema Leroi(Trinity College Dublin), Sara M. Betzhold(Trinity College Dublin), Dearbhail Ryan(Trinity College Dublin), Rachel Fitzpatrick(Trinity College Dublin), Joseph Kane(University of Ulster)
Cited by 12
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223
Impact of the COVID-19 Pandemic on Loneliness and Social Isolation: A Multi-Country Study
|International Journal of Environmental Research and Public Health|2021|208